 Connection
Robert Griffin to Neoplasms, Experimental
This is a "connection" page, showing publications Robert Griffin has written about Neoplasms, Experimental.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.742 |
|
|
|
-
Johnsrud AJ, Jenkins SV, Jamshidi-Parsian A, Quick CM, Galhardo EP, Dings RPM, Vang KB, Narayanasamy G, Makhoul I, Griffin RJ. Evidence for Early Stage Anti-Tumor Immunity Elicited by Spatially Fractionated Radiotherapy-Immunotherapy Combinations. Radiat Res. 2020 12 01; 194(6):688-697.
Score: 0.691
-
Hennings L, Kaufmann Y, Griffin R, Siegel E, Novak P, Corry P, Moros EG, Shafirstein G. Dead or alive? Autofluorescence distinguishes heat-fixed from viable cells. Int J Hyperthermia. 2009 Aug; 25(5):355-63.
Score: 0.020
-
Shafirstein G, Kaufmann Y, Hennings L, Siegel E, Griffin RJ, Nov?k P, Ferguson S, Moros EG. Conductive interstitial thermal therapy (CITT) inhibits recurrence and metastasis in rabbit VX2 carcinoma model. Int J Hyperthermia. 2009; 25(6):446-54.
Score: 0.019
-
Gaul MD, Guo Y, Affleck K, Cockerill GS, Gilmer TM, Griffin RJ, Guntrip S, Keith BR, Knight WB, Mullin RJ, Murray DM, Rusnak DW, Smith K, Tadepalli S, Wood ER, Lackey K. Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines. Bioorg Med Chem Lett. 2003 Feb 24; 13(4):637-40.
Score: 0.013
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|